1. Home
  2. FBRX vs VWAV Comparison

FBRX vs VWAV Comparison

Compare FBRX & VWAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FBRX
  • VWAV
  • Stock Information
  • Founded
  • FBRX N/A
  • VWAV 2024
  • Country
  • FBRX United States
  • VWAV United States
  • Employees
  • FBRX N/A
  • VWAV N/A
  • Industry
  • FBRX Biotechnology: Pharmaceutical Preparations
  • VWAV Computer Software: Prepackaged Software
  • Sector
  • FBRX Health Care
  • VWAV Technology
  • Exchange
  • FBRX Nasdaq
  • VWAV Nasdaq
  • Market Cap
  • FBRX 154.5M
  • VWAV 162.2M
  • IPO Year
  • FBRX N/A
  • VWAV N/A
  • Fundamental
  • Price
  • FBRX $12.94
  • VWAV $13.27
  • Analyst Decision
  • FBRX Strong Buy
  • VWAV
  • Analyst Count
  • FBRX 3
  • VWAV 0
  • Target Price
  • FBRX $68.00
  • VWAV N/A
  • AVG Volume (30 Days)
  • FBRX 94.9K
  • VWAV 372.5K
  • Earning Date
  • FBRX 11-13-2025
  • VWAV 11-26-2025
  • Dividend Yield
  • FBRX N/A
  • VWAV N/A
  • EPS Growth
  • FBRX N/A
  • VWAV N/A
  • EPS
  • FBRX N/A
  • VWAV N/A
  • Revenue
  • FBRX N/A
  • VWAV N/A
  • Revenue This Year
  • FBRX N/A
  • VWAV N/A
  • Revenue Next Year
  • FBRX N/A
  • VWAV N/A
  • P/E Ratio
  • FBRX N/A
  • VWAV N/A
  • Revenue Growth
  • FBRX N/A
  • VWAV N/A
  • 52 Week Low
  • FBRX $4.11
  • VWAV $2.06
  • 52 Week High
  • FBRX $28.68
  • VWAV $14.05
  • Technical
  • Relative Strength Index (RSI)
  • FBRX 49.05
  • VWAV N/A
  • Support Level
  • FBRX $11.00
  • VWAV N/A
  • Resistance Level
  • FBRX $15.01
  • VWAV N/A
  • Average True Range (ATR)
  • FBRX 1.15
  • VWAV 0.00
  • MACD
  • FBRX 0.01
  • VWAV 0.00
  • Stochastic Oscillator
  • FBRX 48.82
  • VWAV 0.00

About FBRX Forte Biosciences Inc.

Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).

About VWAV VisionWave Holdings Inc. Common Stock

VisionWave Holdings Inc is engaged in revolutionizing defense capabilities by integrating artificial intelligence (AI) and autonomous solutions across air, ground, and sea domains. Its innovations range from high-resolution radars and vision systems to radio frequency (RF) sensing technologies are seeking to redefine operational efficiency and precision for military and homeland security applications globally.

Share on Social Networks: